Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of action.
Damiano V, Garofalo S, Rosa R, Bianco R, Caputo R, Gelardi T, Merola G, Racioppi L, Garbi C, Kandimalla ER, Agrawal S, Tortora G. Damiano V, et al. Among authors: kandimalla er. Clin Cancer Res. 2009 Nov 15;15(22):6921-30. doi: 10.1158/1078-0432.CCR-09-1599. Epub 2009 Nov 10. Clin Cancer Res. 2009. PMID: 19903791
Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.
Aurisicchio L, Peruzzi D, Conforti A, Dharmapuri S, Biondo A, Giampaoli S, Fridman A, Bagchi A, Winkelmann CT, Gibson R, Kandimalla ER, Agrawal S, Ciliberto G, La Monica N. Aurisicchio L, et al. Among authors: kandimalla er. Clin Cancer Res. 2009 Mar 1;15(5):1575-84. doi: 10.1158/1078-0432.CCR-08-2628. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240169
104 results